Crook, "
Colistin resistance gene mcr-1 and pHNSHP45 plasmid in human isolates of Escherichia coli and Klebsiella pneumoniae," Lancet Infectious Diseases, vol.
Thus, our therapeutic options against infections due to Carbapenemase producing bacteria are often limited to Tigecycline, Fosfomycin and
Colistin.
Colistin, also known as polymyxin E, is a nephrotoxic and neurotoxic, concentration-dependent bactericidal antibiotic.
"All of Lidl's British meat is Red Tractor assured, meaning our suppliers are required to meet Red Tractor antibiotic use standards, which ban the use of
colistin in poultry, and states that antibiotic usage must be tracked for annual review."
The resistance density for
colistin was less than 1.
among Gram-negative bacteria were isolated with a high rate, almost the only antibiotic that could be used for Acitenobacter strains was
colistin, carbapenem resistance was considerably high in Pseudomonas strains and ESBL positivity was observed with a high rate in Enterobacteriaceae, especially E.
Multi drug resistance was observed in NDM-1 and NDM-5 variants that exhibited resistance to ciprofloxacin, amikacin and aztreonam, and pan drug resistance in other variants like NDM-4, NDM-7 and NDM-9 that showed resistance to nearly all antimicrobials used in clinical practice excluding tigecycline and
colistin.19 In the present work all our isolates harboring NDM-1 variant were showing resistance to ciprofloxacin, amikacin and aztreonam, and Morganella morganii to tigecycline and
colistin as well.
Aerosolized
colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
Colistin and tigecycline resistance in carbapenemase-producing Gram-negative bacteria: emerging resistance mechanisms and detection methods.
Novodiag CarbaR+ combines multiplex qPCR and microarray testing in a single product allowing cost-effective and fast analysis of the most common CPE and
colistin resistance markers.
(1) Therapeutic options against these infections are limited; "second line" agents include
colistin, tigecycline, aminoglycosides, and carbapenems.
For a long time now,
colistin has been used by clinicians as only option to treat these infections.